Skip to content
Screener

West Pharmaceutical Services WST Prepaid & Other Current

Prepaid & Other Current at other companies

AptarGroup logo
AptarGroupATR
$154.05M+3.6%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$109.06M+42.3%
AVT
AvantorAVTR
$187.8M+38.1%
Dow logo
DowDOW
$1.19B+23.8%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$130M-20.7%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$675.99K-57.2%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.53B+43.8%
Enterprise value$24.41B+44.8%
P/E43.4×+8.4×
P/S7.4×+1.6×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099
(in millions, except per share data)June 30,2026December 31,2025
Cash and cash equivalents$435.8$791.3
Accounts receivable, net712.0574.4
Inventories447.4443.9
Other current assets212.3168.6
Total current assets1,807.51,978.2
Property, plant and equipment3,248.63,223.4
Less: accumulated depreciation and amortization1,562.31,497.0
Property, plant and equipment, net1,686.31,726.4

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is West Pharmaceutical Services's prepaid & other current?
West Pharmaceutical Services (WST) reported prepaid & other current of $212.3M in Q2 2026.
How has West Pharmaceutical Services's prepaid & other current changed year-over-year?
West Pharmaceutical Services's prepaid & other current increased by 26.6% year-over-year, from $167.7M to $212.3M.
What is the long-term trend for West Pharmaceutical Services's prepaid & other current?
Over 5 years (2020 to 2025), West Pharmaceutical Services's prepaid & other current has grown at a 26.7% compound annual growth rate (CAGR), from $51.6M to $168.6M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about West Pharmaceutical Services's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude